Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus intrapartum testing for pregnant females Group B Streptococcus (GBS) is the leading cause of ...
The application of targeted genotyping by sequencing (targeted GBS) in marker assisted selection (MAS) and genomics assisted breeding (GAB) has made irrefutable impacts in transforming selection ...
Hosted on MSN
Nexsen accelerates US entry for rapid GBS test with FDA pre-submission and leadership boost
Nexsen Limited ( (AU:NXN)) has provided an announcement. Nexsen has lodged a pre-submission with the US Food and Drug Administration for its rapid Group B Streptococcus point-of-care diagnostic under ...
Jane Plumb told ITV Meridian that change is needed from the government to help prevent the deaths of babies who come into ...
NEW YORK (Reuters Health) - All pregnant women should be routinely screened for Group B streptococcus, a major cause of illness and death among newborns, according to the American College of ...
Group B Streptococcus, which people may call group B strep (GBS), is a type of bacterium that causes GBS disease. GBS can lead to meningitis, which is an infection of the lining of the brain and ...
Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus intrapartum testing for pregnant females With the capability of returning positive results as ...
SUNNYVALE, Calif., March 11, 2024 /PRNewswire/ -- Cepheid announced today that it has received clearance from the U.S. Food and Drug Administration for Xpert® Xpress GBS, a dual-target molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results